About Diabetes
Complications
Warning Signs
Screening Test
Donate Now
E-Lerts™
Index
Latest News
Diabetes Terms
Health & Fitness
Online Press Center
New Research Suggests Lower Chromium Levels Linked to
Increase Risk of Diabetes and CVD
posted 03/10/04
Low chromium status is integrally linked to an increased risk of diseases associated with insulin resistance.
New data was announced, suggesting that high levels of chromium in the body are associated with a lower prevalence of diabetes and cardiovascular disease (CVD) in men. The findings are based on a retrospective analysis of chromium levels in toenail samples of 1,254 males ages 40-75 from the Harvard Health Professional Follow-up Study (1986 - 1994).
"One of the goals of our ongoing research program is to confirm that low chromium status is integrally linked to an increased risk of diseases associated with insulin resistance," remarked James Komorowski, MS, VP Technical Services and Scientific Affairs, Nutrition 21, Inc. "The Harvard findings contribute greatly to that understanding."
Chromium is an essential mineral critical to proper insulin function and needed for carbohydrate, fat and protein metabolism. A number of clinical studies have shown that nutritional supplementation with chromium, in the form of chromium picolinate, helps reduce insulin resistance, and improve blood sugar, triglyceride and cholesterol levels -- all of which are associated with cardiovascular disease or type 2 diabetes. Nutrition 21's Chromax(R) chromium picolinate, patented for nutritional therapies including glucose control, has been used in dozens of clinical trials, and is currently being studied in National Institutes of Health funded research programs at the University of Pennsylvania and Pennington Biomedical Research Center.
"As the scientific and medical communities search for new ways to prevent and treat obesity, diabetes and cardiovascular disease, as well as other chronic conditions like depression, they are increasingly focused on insulin resistance as a common underlying physiological problem," said Gail Montgomery, President and CEO, Nutrition 21, Inc. "A growing body of evidence suggests that low chromium status contributes to the development of insulin resistance. The chromium link to insulin resistance is the foundation of Nutrition 21's business strategy."
Insulin resistance is believed to affect up to one in three Americans. It is predicted that one of the most significant developments for the future diabetes market will be a wider range of drugs aimed at reversing insulin resistance (Diabetes Drugs of Tomorrow Report 2000, Datamonitor).
Further, there are approximately 17 million people in the U.S. with diabetes. Over the 12 months through September 2000, oral anti-diabetics were the leading category of diabetes drugs, with US$5.1 billion of worldwide retail sales, representing the fastest-growing segment of diabetes drugs (Diabetes Market Report 2003/2004, Visiongain).
American Heart Associations 44th Annual Conference on Cardiovascular Disease Epidemiology and prevention.
Source: Diabetes In Control.com.
|
|
|
To be sure and come back to keep up with all the
Latest News and important information for diabetics - and to remind
yourself to manage and control your diabetes, click the yellow link
below
to add a small icon of our Defeat Diabetes® "Torch"
logo to your desktop. All you need to do after that is
click on the "Torch" to open our website.
Remember, we're here for you!
Translate this page into Spanish using FreeTranslation.com. © Copyright 2001 - 2004, Defeat Diabetes Foundation, Inc., All Rights Reserved |
We
subscribe to the HONcode principles